Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
A pilot project offering voluntary heterozygote screening for the delta F508 mutation causing cystic fibrosis (CF) to 638 pregnant women attending two antenatal clinics in the eastern part of Berlin was carried out from 1990-1993. Participation was invited using an information leaflet and inclusion in the study was conditional on written informed consent. Of those invited to participate, only one refused to be tested, on the grounds of non-acceptance of prenatal diagnosis. Eighteen pregnant women were identified as carriers of the delta F508 mutation. All of them and their male partners accepted counselling in which the genetics of CF, its prognosis and treatment were explained, with emphasis on the meaning of heterozygosity, the fact that carriers are healthy, and the risk of an affected fetus when only one parent is identified as a heterozygote. All partners agreed to be tested for the delta F508 R553X and G551D mutations and a second counselling session was carried out after this test result was available. No problems were observed during initial testing but, as in other studies, we found considerable anxiety on being given the result in all couples where the woman tested positive; this was reduced substantially by counselling and when the partner tested negative. All probands found to be carriers stated that they found screening acceptable. In contrast to the cautious statement by the German Berufsverband Medizinische Genetik and the hostile reaction from a representative of the CF self-support organisation towards community-based heterozygote screening for CF, this study shows that CF screening is generally acceptable in this German population and that it is actively taken up by most pregnant women when offered.
Jung
U
U
Department of Human Genetics, Municipal Hospital Berlin-Buch, Germany.
Urner
U
U
Grade
K
K
Coutelle
C
C
D001483:Base Sequence; D032882:Comprehension; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000235:genetics* / Q000523:psychology; D017931:DNA Primers; D005260:Female; D006580:Genetic Carrier Screening; D005817:Genetic Counseling; D005820:Genetic Testing; D005858:Germany; D006801:Humans; D033181:Information Dissemination; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D010342:Patient Acceptance of Health Care; D010865:Pilot Projects; D011247:Pregnancy; D037841:Pregnant People; D011296:Prenatal Diagnosis
D017931:DNA Primers